London · Delayed Price · Currency is GBP · Price in GBX Thalia Therapeutics Statistics
Total Valuation
AIM:THAT has a market cap or net worth of GBP 10.65 million. The enterprise value is 9.15 million.
| Market Cap | 10.65M |
| Enterprise Value | 9.15M |
Important Dates
The last earnings date was Wednesday, September 30, 2026.
| Earnings Date | Sep 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:THAT has 1.78 billion shares outstanding. The number of shares has increased by 77.09% in one year.
| Current Share Class | 1.78B |
| Shares Outstanding | 1.78B |
| Shares Change (YoY) | +77.09% |
| Shares Change (QoQ) | -2.68% |
| Owned by Insiders (%) | 9.65% |
| Owned by Institutions (%) | 34.16% |
| Float | 1.05B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,538.01 |
| PB Ratio | 4.51 |
| P/TBV Ratio | 4.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.02
| Current Ratio | 11.02 |
| Quick Ratio | 11.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.25% and return on invested capital (ROIC) is -42.94%.
| Return on Equity (ROE) | -69.25% |
| Return on Assets (ROA) | -39.88% |
| Return on Invested Capital (ROIC) | -42.94% |
| Return on Capital Employed (ROCE) | -59.02% |
| Weighted Average Cost of Capital (WACC) | 8.16% |
| Revenue Per Employee | 2,405 |
| Profits Per Employee | -487,130 |
| Employee Count | 3 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AIM:THAT has paid 11,614 in taxes.
| Income Tax | 11,614 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.71 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.62 |
| 200-Day Moving Average | 0.58 |
| Relative Strength Index (RSI) | 39.00 |
| Average Volume (20 Days) | 603,597 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:THAT had revenue of GBP 7,216 and -1.46 million in losses. Loss per share was -0.00.
| Revenue | 7,216 |
| Gross Profit | 7,216 |
| Operating Income | -1.45M |
| Pretax Income | -1.45M |
| Net Income | -1.46M |
| EBITDA | n/a |
| EBIT | -1.45M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 1.50 million in cash and no debt, with a net cash position of 1.50 million or 0.00 per share.
| Cash & Cash Equivalents | 1.50M |
| Total Debt | n/a |
| Net Cash | 1.50M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 2.46M |
| Book Value Per Share | 0.00 |
| Working Capital | 2.46M |
Cash Flow
| Operating Cash Flow | -1.46M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -1.46M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -20,124.68% |
| Pretax Margin | -20,123.57% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AIM:THAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -77.09% |
| Shareholder Yield | -77.09% |
| Earnings Yield | -13.17% |
| FCF Yield | -13.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AIM:THAT has an Altman Z-Score of 3.89 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.89 |
| Piotroski F-Score | 1 |